.Pharmacolibrary.Drugs.S_SensoryOrgans.S02A_Antiinfectives.S02AA15_Ciprofloxacin.Ciprofloxacin .Pharmacolibrary.Drugs.S_SensoryOrgans.S02A_Antiinfectives.S02AA15_Ciprofloxacin.Ciprofloxacin| name: | Ciprofloxacin |
| ATC code: | S02AA15 | route: | oral |
| n-compartments | 2 |
Ciprofloxacin is a broad-spectrum fluoroquinolone antibiotic used for the treatment of various bacterial infections, including urinary tract infections, respiratory tract infections, and certain types of gastroenteritis. It is approved for clinical use in many countries and remains a common therapy for susceptible infections.
Population pharmacokinetic parameters in healthy adult volunteers after oral administration.
Hirt, D, et al., & Benaboud, S (2021). Population pharmacokinetics of intravenous and oral ciprofloxacin in children to optimize dosing regimens. European journal of clinical pharmacology 77(11) 1687–1695. DOI:10.1007/s00228-021-03174-1 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34160669
Zahr, N, et al., & Funck-Brentano, C (2021). Ciprofloxacin population pharmacokinetics during long-term treatment of osteoarticular infections. The Journal of antimicrobial chemotherapy 76(11) 2906–2913. DOI:10.1093/jac/dkab275 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34363656
Junkert, AM, et al., & Pontarolo, R (2024). Pharmacokinetics of oral ciprofloxacin in adult patients: A scoping review. British journal of clinical pharmacology 90(2) 528–547. DOI:10.1111/bcp.15933 PUBMED:https://pubmed.ncbi.nlm.nih.gov/37850318